Rep. Elissa Slotkin describes practical, bipartisan approach to health care, water quality, and COVID relief during Monday debate
September 21, 2020
LANSING, Mich. – Rep. Elissa Slotkin highlighted her bipartisan, commonsense approach to tackling the issues that matter most to Michiganders in a WLNS debate that aired live Monday, drawing a sharp contrast with her opponent’s partisan attacks and surface-level knowledge of key issues.
Monday’s debate was the first of three general election debates; Slotkin challenged Paul Junge to the debates, one in each county, shortly after the August primary.
“Voters in the 8th District saw the same Elissa Slotkin they voted to send to Congress: passionate, prepared, pragmatic, mission-focused, and working for bipartisan solutions to the issues they face every day,” said Slotkin campaign spokesman Gordon Trowbridge. “The contrast couldn’t be clearer: When given three individual opportunities to take a stand for the 310,000 8th District residents with a pre-existing condition, and stand up to his own president’s attempts in court to destroy those protections, Paul Junge dodged.”
Slotkin highlighted key accomplishments during her first term in Congress, including supporting and passing bipartisan legislation in the House to lower prescription drug costs and working with the bipartisan Problem Solvers Caucus to kickstart stalled COVID-19 relief negotiations.
Slotkin further challenged Junge to articulate his views on health care. Slotkin repeatedly asked Junge to clarify whether he supports the Trump Administration lawsuit scheduled to begin oral arguments in November before the Supreme Court that is attempting to gut protections for people with pre-existing conditions. Junge failed to clarify his views, resorting instead to misleading, partisan talking points.
“I’m not wanting really to go back and litigate issues about Obamacare and the Affordable Care Act,” Junge responded after Slotkin asked him specifically about the impending lawsuit, falsely characterizing the ACA’s protection of people with pre-existing conditions as “arguments of the past.”
Slotkin highlighted bipartisan passage of her Real Time Benefits Act to bring transparency to drug pricing, and her recent work with the bipartisan Problem Solvers Caucus to offer a compromise framework for negotiations on a COVID-19 relief package.
Slotkin returns to Washington tomorrow to highlight passage of another bipartisan bill, the Strengthening America’s Strategic National Stockpile Act, a bill introduced in July to ensure that front-line health workers never again face supply shortages like those they have faced during the COVID-19 pandemic by making more critical supplies here in the United States.
The subsequent debates are scheduled for Sept. 27 in Detroit and Oct. 6 in Howell.
A career national security professional, Slotkin is a former CIA analyst who joined the agency after the Sept. 11 attacks and later served three tours in Iraq alongside the U.S. military. In her first term in office, she has written bipartisan legislation to address PFAS “forever chemicals” that was enacted into law, and the Real Time Benefits Act to increase transparency in prescription drug prices, which passed the House with bipartisan support.